Figure 2.
Summary of PFS and OS outcomes from phase 3 trials evaluating CDK4/6i + fulvestrant in HR+/HER2– advanced breast cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.